logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation

BlueFocus Intelligent Communications Group (300058.SZ) issued a total of 80 million restricted stocks at a grant price of 4.33 per share to 244 incentive recipients.

date
18:41 07/09/2023
avatar
GMT Eight
BlueFocus Intelligent Communications Group (300058.SZ) announced that the granting conditions of the company's incentive plan have been fulfilled. It has been agreed to set the grant date as September 7, 2023. A total of 80 million restricted stocks will be granted to 244 eligible incentive recipients, at a grant price of 4.33 yuan per share.
Related Articles
HK Stock
HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.
HK Stock
MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.
China Stock
Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.
HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.
HK Stock
MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.
HK Stock
Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.
China Stock
RECOMMEND
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
icon
02/03/2026
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
icon
02/03/2026
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
icon
02/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.